Marta Bustaffa Selected Research

Marta Bustaffa Research Topics

2	COVID-19 10/2022 - 01/2021
1	Fever (Fevers) 01/2024
1	Exanthema (Rash) 10/2023
1	Inflammation (Inflammations) 10/2022
1	Critical Illness (Critically Ill) 10/2022
1	Tonsillitis 01/2022
1	Arthralgia (Joint Pain) 01/2022
1	Eczema 01/2022
1	Job Syndrome (Hyper-IgE Syndrome) 01/2022
1	Lymphadenopathy 01/2022
1	Splenomegaly 01/2022
1	Familial Mediterranean Fever (Periodic Disease) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021
1	Cytokine Release Syndrome 01/2021
1	Pericarditis 06/2020
1	Pathologic Complete Response 06/2020

3	Colchicine FDA LinkGeneric 01/2024 - 01/2021
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2022 - 06/2020
2	InflammasomesIBA 01/2024 - 10/2022
2	Interleukin-1 (Interleukin 1)IBA 01/2021 - 06/2020
1	PyrinIBA 01/2024
1	AA amyloidosisIBA 10/2023
1	NLR ProteinsIBA 10/2022
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	CytokinesIBA 10/2022
1	2,6-dinitrotoluene (DNT)IBA 01/2022
1	dupilumabIBA 01/2022
1	Rheumatoid FactorIBA 01/2021
1	Methylprednisolone FDA LinkGeneric 01/2021
1	GlucocorticoidsIBA 01/2021
1	Monoclonal AntibodiesIBA 06/2020
1	canakinumab FDA Link 06/2020

1	Therapeutics 10/2022
1	Injections 06/2020